Chronic Granulomatous Disease of Childhood

Kendig's Disorders of the Respiratory Tract in Children

Volumn , Issue , 2006, Pages 982-991

  Ambruso, Daniel R ^a,b,c   Johnston, Richard B ^d,e  

^a Children's Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c Bonfils Blood Center   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882552687     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-3695-5.50073-0     Document Type: Chapter

References (126)

1. Berendes H, Bridges RA, Good RA A fatal granulomatosis of childhood. Minn Med 1957, 40:309.
2. Landing BH, Shirkey HS Syndrome of recurrent infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics 1957, 20:431.
3. Bridges RA, Berendes H, Good RA A fatal granulomatous disease of childhood. Am J Dis Child 1959, 97:387.
4. Carson JM, Chadwick DL, Brubacker CA, et al. Thirteen boys with progressive septic granulomatosis. Pediatrics 1965, 35:405.
5. Johnston RB, McMurry JS Chronic familial granulomatosis. Report of five cases and review of the literature. Am J Dis Child 1967, 114:370.
6. Baehner RL, Nathan DG Leukocyte oxidase. Science 1967, 155:835.
7. Macfarlane PS, Speirs AL, Sommerville RG Fatal granulomatous disease of childhood and benign lymphocytic infiltration of the skin (congenital dysphagocytosis). Lancet 1968, 1:844.
8. Quie PG, White JC, Holmes D, Good RA In vitro bactericidal capacity of human polymorphonuclear leukocytes. Diminished activity in chronic granulomatous disease of childhood. J Clin Invest 1968, 46:668.
9. Baehner RL, Nathan DG Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med 1968, 278:971.
10. Quie PG, Kaplan EL, Page AR, et al. Defective polymorphonuclear leukocyte function and chronic granulomatous disease in two female children. N Engl J Med 1968, 279:967. and 1968:278;976.
11. Curnutte JT, Kipnes RS, Babior BM Defect in pyridine nucleotide-dependent superoxide production by a particulate fraction from the granulocytes of patients with chronic granulomatous disease. N Engl J Med 1975, 293:628.
12. McPhail LC, Dechatelet LR, Shirley PS, et al. Deficiency of NADPH oxidase activity in chronic granulomatous disease. J Pediatr 1977, 90:213.
13. Segal AW, Jones OTG Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature 1978, 276:515.
14. -245 in chronic granulomatous disease. A multicenter European evaluation of its incidence and relevance. N Engl J Med 1983, 308:245.
15. Royer-Pokora B, Kunkel LM, Monaco AP, et al. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 1986, 322:32.
16. Dinauer MC, Orkin SH, Brown R, et al. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 1987, 327:717.
17. -245. Nature 1987, 327:720.
18. Dinauer MC, Pierce EA, Bruns GAP, et al. Human neutrophil cytochrome b light chain (p22-phox): gene structure, chromosomal location, and mutation in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 1990, 86:1729.
19. Nunoi H, Rotrosen D, Gallin JI, Malech HL Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science 1988, 242:1298.
20. Volpp BD, Nauseef WM, Clark RA Two cytosolic neutrophil NADPH oxidase components absent in autosomal chronic granulomatous disease. Science 1988, 242:1295.
21. Volpp BD, Nauseef WM, Donelson JE, et al. Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. proc Natl Acad Sci U S A 1989, 86:7195.
22. Erratum: proc Natl Acad Sci U S A 1989, 86:9563.
23. c-src. Science 1990, 248:727.
24. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 2000, 79:155.
25. Johnston RB Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 2001, 8:17.
26. Segal BH, Leto TL, Gallin JI, et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 2000, 79:170.
27. DeBoer M, Bolscher BGJM, Sijmons RH, et al. Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction. Prenat Diagn 1992, 12:773.
28. Forehand JR, Nauseef WM, Curnutte JT, Johnston RB Inherited disorders of phagocyte killing. The Metabolic and Molecular Bases of Inherited Disease 1995, McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
29. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004, 114:462.
30. Goldblatt D, Butcher J, Thrasher AJ, et al. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr 1999, 134:780.
31. Fleming GM, Kleinerman J, Doershuk CF, Perrin EV Chronic granulomatous disease of childhood. An unusual case of honeycomb lung. Chest 1975, 68:834.
32. Dilworth JA, Mandell GL Adults with chronic granulomatous disease of "childhood.". Am J Med 1977, 63:233.
33. Cale CM, Jones AM, Goldblatt D Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Immunol 2000, 120:351.
34. Forrest CB, Forehand JR, Axtell RA, et al. Clinical features and current management of chronic granulomatous disease. Hematol Oncol Clin North Am 1988, 2:253.
35. Segal BH, DeCarlo ES, Kwon-Chung KJ, et al. Aspergillus nidulans infection in chronic granulomatous disease. Medicine 1998, 77:345.
36. White CJ, Kwon-Chung KJ, Gallin JI Chronic granulomatous disease of childhood. An unusual case of infection with Aspergillus nidulans var. echinulatus. Am J Clin Pathol 1988, 90:312.
37. Kawashima A, Kuhlman JE, Fishman EK, et al. Pulmonary Aspergillus chest wall involvement in chronic granulomatous disease. CT and MRI findings. Skeletal Radiol 1991, 20:487.
38. Wolfson JJ, Quie PG, Laxdal SD, Good RA Roentgenologic manifestations of children with a genetic defect of polymorphonuclear leukocyte function. Chronic granulomatous disease of childhood. Radiology 1968, 91:37-48.
39. Ambruso DR The anemias of chronic diseases. Hematology: A Problem-Oriented Approach 1996, 179-186. Williams & Wilkins, Baltimore. S. Gross, S. Roath (Eds.).
40. Johnston RB, Newman SL Chronic granulomatous disease. Pediatr Clin North Am 1977, 24:365.
41. O'Neil KM, Herman JH, Modlin JF, et al. Pseudomonas cepacia. An emerging pathogen in chronic granulomatous disease. J Pediatr 1986, 108:940.
42. Lacy DE, Spencer DA, Goldstein A, et al. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicemia. J Infect 1993, 27:301.
43. Johnston RB Unusual forms of an uncommon disease (chronic granulomatous disease). J Pediatr 1976, 88:172.
44. Ochs HD, Igo RP The NBT slide test. A simple screening method for detecting chronic granulomatous disease and female carriers. J Pediatr 1973, 83:77.
45. Meerhof J, Roos D Heterogeneity in chronic granulomatous disease detected with an improved nitroblue tetrazolium slide test. J Leukoc Biol 1986, 39:699.
46. Vowells SJ, Sekhsaria S, Malech HL, et al. Flow cytometric analysis of the granulocyte respiratory burst. A comparison study of fluorescent probes. J Immunol Meth 1995, 178:89.
47. Johnston RB, Keele BB, Misra HP, et al. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J Clin Invest 1975, 55:1357.
48. Verhoeven AJ, Van Schaik MLJ, Roos D, Weening RS Detection of carriers of the autosomal form of chronic granulomatous disease. Blood 1988, 71:505.
49. Huu TP, Dumez Y, Marquetty C, et al. Prenatal diagnosis of chronic granulomatous disease (CGD) in four high risk male fetuses. Prenat Diagn 1987, 7:253.
50. Levinsky R, Harvey B, Nicolaides K, Rodeck C Antental diagnosis of chronic granulomatous disease. Lancet 1986, 1:50.
51. Pelham A, O'Reilly M-AJ, Malcolm S, et al. RFLP and deletion analysis for X-linked chronic granulomatous disease using the cDNA probe. Potential for improved prenatal diagnosis and carrier determination. Blood 1990, 76:820.
52. 2 oxidoreductase in human neutrophils after stimulation with phorbol-myristate acetate. J Biol Chem 1990, 265:924.
53. Erratum: J Biol Chem 1990, 265:19370.
54. Ambruso DR, Cusack N, Thurman G NADPH oxidase activity of neutrophil specific granules. Requirements for cytosolic components and evidence of assembly during cell activation. Mol Genet Metab 2004, 81:313.
55. Clark RA, Volpp BD, Leidal KG, Nauseef WM Two cytosolic components of the human neutrophil respiratory burst oxidase translocate to the plasma membrane during cell activation. J Clin Invest 1990, 85:714.
56. Segal AW, Jones OTG Subcellular distribution and some properties of the cytochrome b component of the microbicidal oxidase system of human neutrophils. Biochem J 1979, 182:181.
57. Borregaard N, Heiple JM, Simons ER, Clark RA Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase. Translocation during activation. J Cell Biol 1983, 97:52.
58. Parkos CA, Allen RA, Cochrane CG, Jesaitis AJ Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest 1987, 80:732.
59. -245 subunits from neutrophils in X-linked chronic granulomatous disease. Nature 1987, 326:88.
60. -245 is a flavo-cytochrome containing FAD and the NADPH-binding site of the microbicidal oxidase of phagocytes. Biochem J 1992, 284:781.
61. 2- generating oxidase from human neutrophils. Identification of a flavoprotein component that is deficient in a patient with chronic granulomatous disease. J Biol Chem 1983, 258:6352.
62. Quinn MT, Mullen ML, Jesaitis AJ Human neutrophil cytochrome b contains multiple hemes. Evidence for heme associated with both subunits. J Biol Chem 1992, 267:7303.
63. 558. Blood 1992, 79:1563.
64. Lomax KR, Leto TL, Nunoi H, et al. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 1989, 245:409.
65. Erratum: Science 1989, 246:987.
66. 2 oxidoreductase activity in human neutrophils. J Clin Invest 1989, 83:757.
67. Clark RA, Malech HL, Gallin JI, et al. Genetic variants of chronic granulomatous disease. Prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med 1989, 321:647.
68. -245. J Biol Chem 1992, 267:16767.
69. Wientjes FB, Hsuan JJ, Totty NF, Segal AW p40-phox, a third cytosolic component of the activation complex of the NADPH oxidase to contain src homology 3 domains. Biochem J 1993, 296:557.
70. Abo A, Pick E, Hall A, et al. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 1991, 353:668.
71. Knaus UG, Heyworth PG, Evans T, et al. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science 1991, 254:1512.
72. Kwong CH, Malech HL, Rotrosen D, Leto TL Regulation of human neutrophil NADPH oxidase by rho-related G-proteins. Biochemistry 1993, 32:5711.
73. Park JW, El Benna J, Scott KE, et al. Isolation of a complex of respiratory burst oxidase components from resting neutrophil cytosol. Biochemistry 1994, 33:2907.
74. Finan P, Shimizu Y, Gout I, et al. An SH3 domain and proline-rich sequence mediate an interaction between two components of the phagocyte NADPH oxidase complex. J Biol Chem 1994, 269:13752.
75. Sumimoto H, Kage Y, Nunoi H, et al. Role of src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. proc Natl Acad Sci U S A 1994, 91:5345.
76. de Mendez I, Garrett MC, Adams AG, Leto TL Role of p67-phox SH3 domains in assembly of the NADPH oxidase system. J Biol Chem 1994, 269:16326.
77. Cross AR, Yarchover JL, Curnutte JT The superoxide-generating system of human neutrophils possesses a novel diaphorase activity Evidence for distinct regulation of electron flow within NADPH oxidase by p67-phox and p47-phox. J Biol Chem 1994, 269:21448.
78. Cross AR, Curnutte JT The cytosolic activating factors p47-phox and p67-phox have distinct roles in the regulation of electron flow in NADPH oxidase. J Biol Chem 1995, 270:6543.
79. Leavey PJ, Gonzalez-Aller C, Thurman G, et al. A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity. J Biol Chem 2002, 277:45181.
80. Rhee SG, Kang SW, Chang TS, et al. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 2002, 52:35.
81. 2-) production by the NADPH oxidase enzyme system. Blood 2003, 102:273a.
82. McPhail LC, Shirley PS, Clayton CC, Snyderman R Activation of the respiratory burst enzyme from human neutrophils in a cell-free system. Evidence for a soluble cofactor. J Clin Invest 1985, 75:1735.
83. Curnutte JT Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphospyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system. J Clin Invest 1985, 75:1740.
84. Roos D, de Boer M, Kuribayashi F, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996, 87:1663.
85. Cross AR, Noack D, Rae J, et al. Hematologically important mutations. The autosomal recessive forms of chronic granulomatous disease (first update). Blood Cells Mol Dis 2000, 26:561.
86. Heyworth PG, Curnutte JT, Rae J, et al. Hematologically important mutations. X-linked chronic granulomatous disease (second update). Blood Cells Mol Dis 2001, 27:16.
87. Heyworth PG, Cross AR, Curnutte JT Chronic granulomatous disease. Curr Opin Immunol 2003, 15:578.
88. Rae J, Newburger PE, Dinauer MC, et al. X-linked chronic granulomatous disease. Mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Am J Hum Genet 1998, 62:1320.
89. Noack D, Rae J, Cross AR, et al. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox. Mutations not arising in the NCF-1 pseudogenes. Blood 2001, 97:305.
90. Roesler J, Curnutte JT, Rae J, et al. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. Blood 2000, 95:2150.
91. Noack D, Rae J, Cross AR, et al. Autosomal recessive chronic granulomatous disease caused by novel mutations in NCF-2, the gene encoding the p67-phox component of phagocyte NADAPH oxidase. Hum Genet 1999, 105:460.
92. Borgato L, Bonizzato A, Lunardi C, et al. A 1.1-kb duplication in the p67-phox gene causes chronic granulomatous disease. Hum Genet 2001, 108:504.
93. Ambruso DR, Knall C, Abell AN, et al. Human neutrophil immunodeficiency syndrome is associated with an inhibitory Rac2 mutation. proc Natl Acad Sci U S A 2000, 97:4654.
94. Kurkchubasche AG, Panepinto JA, Tracy TF, et al. Clinical features of a human Rac2 mutation. A complex neutrophil dysfunction disease. J Pediatr 2001, 139:141.
95. Williams DA, Tao W, Kim C, et al. A dominant negative mutation of the hematopoietic-specific RhoGTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 2000, 96:1646.
96. Baehner RL, Johnston RB, Nathan DG Comparative study of the metabolic and bactericidal characteristics of severely glucose-6-phosphate dehydrogenase deficient polymorpho-nuclear leukocytes from children with chronic granulomatous disease. J Reticuloendothel Soc 1972, 12:150.
97. Gray GR, Klebanoff SJ, Stamatayannopoulos G, et al. Neutrophil dysfunction, chronic granulomatous disease and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet 1973, 2:530.
98. Mamlok RJ, Mamlok V, Mills GC, et al. Glucose-6-phosphate dehydrogenase deficiency, neutrophil dysfunction and Chromobacterium violaceum sepsis. J Pediatr 1987, 111:852.
99. Fischer A, Segal AW, Seger R, Weening RS The management of chronic granulomatous disease. Eur J Pediatr 1993, 152:896.
100. Margolis DM, Melnick DA, Alling DW, Gallin JI Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 1990, 162:723.
101. Mouy R, Fischer A, Vilmer E, et al. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989, 114:555.
102. International Chronic Granulomatous Disease Study Group A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991, 324:509.
103. Mouy R, Seger R, Bourquin JP, et al. Interferon gamma for chronic granulomatous disease. N Engl J Med 1991, 325:1516.
104. Gallin JI, Alling DW, Malech HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003, 348:2416.
105. Pogrebniak HW, Gallin JI, Malech HL, et al. Surgical management of pulmonary infections in chronic granulomatous disease of childhood. Ann Thorac Surg 1993, 55:844.
106. Sponseller PD, Malech HL, McCarthy EF, et al. Skeletal involvement in children who have chronic granulomatous disease. J Bone Joint Surg Am 1991, 73:37.
107. Spencer DA, John P, Ferryman SR, et al. Successful treatment of invasive pulmonary aspergillosis in chronic granulomatous disease with orally administered itraconazole suspension. Am J Respir Crit Care Med 1994, 149:239.
108. Donnelly JP, DePauw BE Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity. Clin Microbiol Infect 2004, 10:107.
109. Ambruso DR, Johnston RB Chronic granulomatous disease. Pediatric Respiratory Disease: Diagnosis and Treatment 1993, 697-702. WB Saunders, Philadelphia. B.C. Hilman (Ed.).
110. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft. A survey of the European experience, 1985-2000. Blood 2002, 100:4344.
111. Del Giudice I, Iori AP, Mengarelli A, et al. Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature. Ann Hematol 2003, 82:189.
112. Horwitz ME, Barrett AJ, Brown MR, et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 2001, 344:881.
113. Chin TW, Steim ER, Falloon J, Gallin JI Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr 1987, 111:349.
114. Danziger RN, Goren AT, Becker J, et al. Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease. J Pediatr 1993, 122:303.
115. 2- production by B lymphocytes lacking the respiratory burst oxidase subunit p47-phox after trans-fection with an expression vector containing a p47-phox cDNA. proc Natl Acad Sci U S A 1992, 89:10174.
116. Cobbs CS, Malech HL, Leto TL, et al. Retroviral expression of recombinant p47-phox protein by Epstein-Barr virus-transformed B lymphocytes from a patient with autosomal chronic granulomatous disease. Blood 1992, 79:1829.
117. Maly FE, Schuerer-Maly CC, Quilliam L, et al. Restitution of superoxide generation in autosomal cytochrome-negative chronic granulomatous disease (A22° CGD)-derived B lymphocyte cell lines by transfection with p22-phox cDNA. J Exp Med 1993, 178:2047.
118. Porter CD, Parkar MH, Levinsky RJ, et al. X-linked chronic granulomatous disease. Correction of NADPH oxidase defect by retrovirus-mediated expression of gp91-phox. Blood 1993, 82:2196.
119. Thrasher A, Chetty M, Casimir C, Segal AW Restoration of superoxide generation to a chronic granulomatous disease-derived B-cell line by retrovirus mediated gene transfer. Blood 1992, 80:1125.
120. Zhen L, King AAJ, Xiao Y, et al. Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91-phox. proc Natl Acad Sci U S A 1993, 90:9832.
121. 558 defective forms of chronic granulomatous disease. Blood 1994, 84:53.
122. Sekhsaria S, Gallin JI, Linton GF, et al. Peripheral blood progenitors as a target for genetic correction of p47-phox deficient chronic granulomatous disease. proc Natl Acad Sci U S A 1993, 90:7446.
123. Goebel WS, Dinauer MC Retroviral-mediated gene transfer and nonmyeloablative conditioning. Studies in a murine X-linked chronic granulomatous disease model. J Pediatr Hematol Oncol 2002, 24:787.
124. Dinauer MC, Gifford MA, Pech N, et al. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease. Blood 2001, 97:3738.
125. Malech HL, Maples PB, Whiting-Theobald N, et al. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. proc Natl Acad Sci U S A 1997, 94:12133.
126. Chinen J, Puck JM Successes and risks of gene therapy in primary immunodeficiencies. J Allergy Clin Immunol 2004, 113:595.